Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

In the light of these breakthroughs, the scientific community— with the supportof FIGOaswell asother international scientific societies and agencies—felt that the time had come to revise the staging of some of the gynecologic cancers. [...] It is the aim of the FIGO Committee onGynecologicOncology toupdate the stagingof this disease in the next 3 years. [...] The IGCS, the Gynecologic Cancer Intergroup (GCIG), the American Society of Gynecologic Oncologists (SGO), and the AJCC, together with the International Society of Gynecological Pathologists (ISGyP), agreed to collaborate and formed the Enlarged Committee (see List of Members). [...] The document with the amendments to the staging for vulvar, cervical, and endometrial cancer was extensively discussed by the attendees. [...] Following the amendments and what has emerged over the past 3 years from thediscussions anddebates, various international experts— whowere actively involved in the revisionprocess—were approached to write accompanying commentaries to provide the scientific community with opinions and insights on the revisions to the staging of these 3 diseases.